Tus kws kho mob
QP4-21 Commercial Pharmacy Benefit Exclusion for OxlumoTM
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1351 - 1360 ntawm 4179
Tus kws kho mob
QP1-21 Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 13, 2021
Tus kws kho mob
QP3-21 Commercial and MHCP Pharmacy Benefit Exclusion for Barhemsys® and Monoferric®
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 13, 2021
Tus kws kho mob
BC-COM_PharmProgPolicyNotifctn_2021-0301.pdf
Tus kws kho mob
QP123-20 Validation of National Drug Codes Submitted with Medical Drug Claims
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2020
Tus kws kho mob
P81R1-20 Update: eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 04, 2021
Tus kws kho mob
P5-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 04, 2021
Tus kws kho mob
P1-21 Retro Reviews for Post-Acute Care and Home Health Prior Authorizations
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 04, 2021